Literature DB >> 21053676

Severe hypotension and ischemic stroke after disulfiram-ethanol reaction.

Maria G Prancheva1, Sasha A Krasteva, Stoilka G Tufkova, Teodora P Karaivanova, Veselina V Nizamova, Yanko T Iliev.   

Abstract

Disulfiram (tetraethylthiuram disulfide) has been used for almost 60 years in the treatment of alcohol addiction. It causes aversive behavior due to disulfiram-ethanol reaction (DER). The classical DER includes flush, sweating, tremor, nausea, vomiting, tachycardia, moderate decrease in blood pressure and restlessness. Complete recovery is the usual outcome in clinical settings. Life-threatening reactions are rare but sometimes occur. We present a case of a 53-year-old man developing severe hypotension and ischemic stroke as a result of disulfiram treatment and ethanol intake. Use of adrenalin as a drug of choice in this critical condition, together with other therapeutic approaches led to stabilization of hemodynamics and reversal of neurological symptoms. Our case had a favorable outcome, but it should be remembered that patients unable to comply to the strong restrictions in treatment for alcohol rejection are not eligible for this therapeutic modality used in the management of alcohol dependency.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21053676     DOI: 10.2478/v10153-010-0009-y

Source DB:  PubMed          Journal:  Folia Med (Plovdiv)        ISSN: 0204-8043


  2 in total

1.  Recognition of a disulfiram ethanol reaction in the emergency department is not always straightforward.

Authors:  Kristof Segher; Liesbeth Huys; Tania Desmet; Evi Steen; Stefanie Chys; Walter Buylaert; Peter De Paepe
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

2.  Can Lipoic Acid Attenuate Cardiovascular Disturbances Induced by Ethanol and Disulfiram Administration Separately or Jointly in Rats?

Authors:  Anna Bilska-Wilkosz; Magdalena Kotańska; Magdalena Górny; Barbara Filipek; Małgorzata Iciek
Journal:  Oxid Med Cell Longev       Date:  2019-11-22       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.